SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882095-23-000014
Filing Date
2023-04-27
Accepted
2023-04-27 16:05:24
Documents
14
Period of Report
2023-04-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20230427.htm   iXBRL 8-K 41298
2 EX-99.1 exhibit991earningspressrel.htm EX-99.1 449777
6 LOGO gcp_primarylargea.jpg GRAPHIC 824580
  Complete submission text file 0000882095-23-000014.txt   1772166

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20230427.xsd EX-101.SCH 1912
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20230427_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20230427_pre.xml EX-101.PRE 12519
8 EXTRACTED XBRL INSTANCE DOCUMENT gild-20230427_htm.xml XML 11429
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 23856768
SIC: 2836 Biological Products, (No Diagnostic Substances)